Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Blood

• Publication date

  2012-10-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2012-02-413252PMID 22915648PMCID PMC3466966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TSLP Signaling Network Revealed by SILAC-Based Phosphoproteomics*

  2012cited by this paper
• Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

  2012cited by this paper
• Genetic resistance to JAK 2 enzymatic inhibitors is overcome by HSP 90 inhibition

  2012cited by this paper
• Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.

  2012cited by this paper
• Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

  2011cited by this paper
• Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

  2011cited by this paper
• Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia

  2011cited by this paper
• Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

  2011cited by this paper
• Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation

  2011cited by this paper
• Thymic Stromal Lymphopoietin Is a Key Mediator of Breast Cancer Progression

  2011cited by this paper
• Distinct Signal Codes Generate Dendritic Cell Functional Plasticity

  2010cited by this paper
• Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia

  2010cited by this paper
• Effects of transmembrane and juxtamembrane domains on proliferative ability of TSLP receptor.

  2010cited by this paper
• Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

  2010cited by this paper
• Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7–induced signaling

  2010cited by this paper
• Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

  2010cited by this paper
• Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function

  2010cited by this paper
• The role of thymic stromal lymphopoietin (TSLP) in allergic disorders.

  2010cited by this paper
• Site-directed mutagenesis reveals a unique requirement for tyrosine residues in IL-7Rα and TSLPR cytoplasmic domains in TSLP-dependent cell proliferation

  2010cited by this paper
• JAK mutations in high-risk childhood acute lymphoblastic leukemia

  2009cited by this paper
• Tyrosine kinases and their substrates in B lymphocytes

  2009cited by this paper
• Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia

  2009cited by this paper
• TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis

  2009cited by this paper
• Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

  2009cited by this paper
• Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

  2009cited by this paper
• Two Domains of the Erythropoietin Receptor Are Sufficient for Jak2 Binding/Activation and Function

  2006cited by this paper
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

  2005cited by this paper
• Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation.

  2005cited by this paper
• A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  2005cited by this paper
• Absence of an Essential Role for Thymic Stromal Lymphopoietin Receptor in Murine B-Cell Development

  2004cited by this paper
• Uncoupling of Proliferation and Stat5 Activation in Thymic Stromal Lymphopoietin-Mediated Signal Transduction1

  2002cited by this paper
• Contribution of the Box 1 and Box 2 Motifs of Cytokine Receptors to Jak1 Association and Activation*

  2002cited by this paper
• Penicillin-Binding Proteins inLeptospira interrogans

  2001cited by this paper
• Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation

  2001cited by this paper
• Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR.

  2001cited by this paper
• Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells1

  2001cited by this paper
• Molecular cloning of a human novel type I cytokine receptor related to δ1/TSLPR

  2001cited by this paper
• Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin

  2000cited by this paper
• Molecular cloning and characterization of CRLM-2, a novel type I cytokine receptor preferentially expressed in hematopoietic cells.

  2000cited by this paper
• Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor

  2000cited by this paper
• Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain.

  2000cited by this paper
• Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction.

  1999cited by this paper
• Function and Signal Transduction Mediated by the Interleukin 3 Receptor System in Hematopoiesis

  1996cited by this paper
• The Conserved Box 1 Motif of Cytokine Receptors Is Required for Association with JAK Kinases (*)

  1995cited by this paper
• A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells.

  1994cited by this paper
• JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

  1993cited by this paper

• Thymic stromal lymphopoietin in leukemia: A double-edged sword?

  2025cites this paper
• TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps

  2025cites this paper
• Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening

  2024cites this paper
• Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19

  2023cites this paper
• JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies

  2022cites this paper
• The Role of Genetics and Synergistic Effect of Targeting Common Genetic Mutations in Acute Lymphoblastic Leukemia (ALL).

  2022cites this paper
• Combination of FLG mutations and SNP of TSLP (rs1898671) influence on atopic dermatitis occurrence

  2021cites this paper
• Acute Leukemias

  2021cites this paper
• Genetics and Diagnostic Approach to Lymphoblastic Leukemia/Lymphoma.

  2021cites this paper
• Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies

  2021cites this paper
• In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL

  2021cites this paper
• Associations among phthalate exposure, DNA methylation of TSLP, and childhood allergy

  2021cites this paper
• Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments

  2021cites this paper
• Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia.

  2020cites this paper
• Philadelphia-Like Acute Lymphoblastic Leukemia: A Systematic Review.

  2020cites this paper
• Ph-Like ALL: Diagnosis and Management

  2020cites this paper
• BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.

  2020cites this paper
• Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.

  2020cites this paper
• Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in CRLF2-Rearranged Ph-like ALL

  2020cites this paper
• BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.

  2020cites this paper
• Naturally occurring and synthetic constitutive-active cytokine receptors in disease and therapy.

  2019cites this paper
• Mutagenic players in ALL progression and their associated signaling pathways.

  2019cites this paper
• CRLF2蛋白在成人非Ph阳性急性B淋巴细胞白血病中的表达特点及其预后意义

  2018cites this paper
• Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions

  2018cites this paper
• Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations

  2018cites this paper
• SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia

  2018cites this paper
• Philadelphia chromosome-like acute lymphoblastic leukemia.

  2017cites this paper
• Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.

  2017cites this paper
• The promise of Janus kinase inhibitors in the treatment of hematological malignancies

  2017cites this paper
• A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.

  2017cites this paper
• Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.

  2017influential citation
• Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia

  2016cites this paper
• Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

  2016cites this paper
• CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.

  2016cites this paper
• The role of TSLP pathway in the development of B-Cell Acute Lymphoblastic Leukemia

  2016cites this paper
• High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement

  2016cites this paper
• Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target

  2015cites this paper
• Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.

  2015cites this paper
• Education and training

  2014cites this paper
• Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance

  2014cites this paper
• The importance of TSLP in allergic disease and its role as a potential therapeutic target

  2014cites this paper
• Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia

  2014cites this paper
• TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling

  2014cites this paper
• Lymphoid malignancies: Another face to the Janus kinases.

  2013cites this paper
• Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia

  2013cites this paper